Aller au contenu principal
Accès ouvert déclaré 2025 article

The Translational Research Program in Cancer Differences across Populations

2Citations signalées, ce qui n’est pas une note de qualité
12Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Cancer incidence and mortality vary substantially across populations. The Translational Research Program in Cancer Differences across Populations (TRPCDP) was established in 2020 to address differences in cancer incidence and mortality rates within the United States, with a particular focus on colorectal cancer. METHODS: The TRPCDP centralized data acquisition and harmonization across three sites in the United States to create a well-annotated resource of colorectal cancer tumors across four populations: African American/Black, Alaska Native, Hispanic/Latino/Latina, and non-Hispanic White. Using a case-control framework, patients with lethal colorectal cancer were matched to two controls with nonlethal colorectal cancer. Formalin-fixed, paraffin-embedded tumor and normal tissue were retrieved and sent for centralized pathology review, followed by DNA and RNA extraction and tissue microarray development. Multiomics and spatial profiling are underway to evaluate the transcriptome, proteome, and microbiome. Patient demographic and clinical data were obtained by medical record review, patient self-report, or linkage to cancer registries. Additional health-related factors were assessed using geospatial linkage. RESULTS: The virtual biorepository includes 7,181 patients [African American (n = 1,345), Alaska Native (n = 1,640), Hispanic (n = 1,659), and non-Hispanic White (n = 2,537)]. Tissue blocks (1,594 tumor and 728 normal colon samples) were selected for 938 patients. To date, DNA and RNA have been extracted (n = 831), and tissue microarrays have been constructed (n = 414). Transcriptomic analysis, spatial tumor profiling (multiplex immunofluorescence, PhenoCycler, and GeoMx), and microbiome data (16S rRNA sequencing and digital droplet PCR) are available. CONCLUSIONS: The TRPCDP has developed a clinically annotated biorepository for future molecular epidemiology studies. IMPACT: The TRPCDP is a unique program that supports collaborative research, community engagement, and pipeline development for the next generation of scientists.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The Translational Research Program in Cancer Differences across Populations
Date Crossref
27/06/2025
Éditeur
American Association for Cancer Research (AACR)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Colorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsMolecular Biology Techniques and Applications

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.